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A B S T R A C T
Purpose: We investigated the various possible reasons for uncontrolled seizures in patients 18 years of
age and older to determine the impact of pseudointractability. We also tried to investigate the various
forms of pseudointractability.
Methods: In this cross-sectional study, all patients 18 years of age and older with their ﬁrst seizure
occurring at least six months prior to the referral date, taking at least one antiepileptic drug (AED) and
having at least one seizure in the past three months were studied. The presumed reason for uncontrolled
seizures was arbitrarily considered to be one of these ﬁve categories: Poor compliance; Wrong
medication (misclassiﬁcation); Wrong dose of the correct medication; Diagnosis other than epilepsy;
and ﬁnally, Medically-refractory epilepsy. Statistical analyses were performed using Chi-square and
Fisher’s Exact tests, and a P value less than 0.05 was considered signiﬁcant.
Results: 350 patients were referred to us due to uncontrolled seizures. One hundred ninety-one (55%)
were male and 159 (45%) were female. Twelve percent of the patients had diagnoses other than epilepsy,
40% had indeed medically-refractory epilepsy; 29% were taking the wrong AEDs (misclassiﬁed epilepsy);
18% were taking suboptimal doses of AEDs; and 1% had poor drug compliance. The most common reason
for uncontrolled seizures among patients with idiopathic generalized epilepsy was taking the wrong
AED. However, among patients with focal epilepsy, true medically-refractory epilepsy was the most
common reason.
Conclusion: Uncontrolled seizures are a commonly encountered problem, especially at epilepsy clinics
and one should consider all possible reasons for these uncontrolled seizures. The mainstay for making a
correct diagnosis is a detailed clinical history.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Epilepsy is deﬁned as a condition characterized by recurrent
seizures due to a primary disturbance of brain function, not
provoked by transient insults such as fever or metabolic
disturbances (e.g., hypoglycemia).1 Epilepsy ranks among the
most common chronic neurological disorders. When evaluating a
patient with a possible seizure disorder, one must ﬁrst determine
whether epileptic seizures have truly occurred, or whether a
disorder exists that mimics epilepsy. The mainstay of treatment in
patients with epilepsy is antiepileptic drug (AED) therapy. In the
past decade, many new AEDs have been introduced so that there* Corresponding author at: Neurosciences Research Center, Shiraz University of
Medical Sciences, Shiraz, Iran. Tel.: +98 9352274990.
E-mail addresses: asadipoa@sums.ac.ir, aliasadipooya@yahoo.com
(A.A. Asadi-Pooya).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.01.010are now more than 20 medications available to treat epilepsy. The
physician therefore, has many choices and can tailor therapy
depending upon individual circumstance. However, having many
alternatives also allows for the possibility of choosing an
inappropriate or suboptimal agent that may result in having
uncontrolled seizures (pseudointractability).2 On the other hand,
more than 30% of individuals with epilepsy have persistent
seizures despite use of appropriate AEDs (medically-refractory).3
In this study, we investigated the various possible reasons for
uncontrolled seizures (which had been presumed to be epileptic
seizures) in patients 18 years of age and above to determine the
impact of pseudointractability. We also tried to investigate the
various forms of pseudointractability in these patients.4
2. Methods and materials
In this cross-sectional retrospective chart review study, all
patients 18 years of age and above who were referred to thevier Ltd. All rights reserved.
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which is the only epilepsy clinic in south Iran, from January 2009
through October 2009, due to having presumably uncontrolled
epileptic seizures were studied. Inclusion criteria were as follows:
age 18 years or above at the time of referral; with the ﬁrst seizure
occurring at least six months prior to the referral date; taking at
least one AED since the presumed diagnosis; and ﬁnally, having at
least one seizure in the past three months (i.e., after three months
of taking any AEDs). A clinical diagnosis of the patient’s disorder
was made based on the clinical grounds and all patients had to be
under the care of the epileptologist at our institution. Outpatient
electroencephalography (EEG) was performed at the time of
referral. Inpatient video-EEG monitoring study was performed
when considered necessary for the diagnosis. Other tests (i.e.,
blood tests, imaging studies, EKG, etc.) were requested based upon
the clinical judgment.
Age, age at seizure onset, seizure type(s), seizure frequency,
medication(s), other clinical ﬁndings (i.e., imaging studies, blood
tests, etc.), and ﬁnal diagnosis of all patients were registered
routinely. Demographic variables and relevant clinical variables
were summarized descriptively to characterize the study popula-
tion. The patients were assessed and categorized when we had
enough information available (often times, in the second visit). The
epileptologist undertook the classiﬁcation and categorization. The
presumed reason for uncontrolled seizures was arbitrarily
considered to be one of these ﬁve categories: (1) poor compliance,
deﬁned as more than one missed dose per week; (2) wrong
medication (misclassiﬁed epilepsy), deﬁned as inappropriate AED
for the syndromic diagnosis (e.g., gabapentin for childhood
absence epilepsy or ethosuximide for temporal lobe seizures2);
(3) wrong (suboptimal) dose of the correct medication; (4)
diagnosis other than epilepsy (e.g., psychogenic non-epileptic
seizures, syncope, etc.); and ﬁnally, (5) medically-refractory
epilepsy, deﬁned as failure of adequate trials of two tolerated,
appropriately chosen and used AED schedules (whether asTable 1
Final diagnosis of adult patients who were referred with uncontrolled seizures.
Final Diagnosis Number (%) Syndromi
Focal epilepsy (other than temporal lobe epilepsy) 101 (29)
Idiopathic generalized epilepsy 89 (25) Juvenile m
Generaliz
Juvenile a
Others 
Temporal lobe epilepsy 75 (21)
Symptomatic generalized epilepsy 27 (8) Lennox–G
Others 
Unclassiﬁed epileptic seizures 15 (4)
Diagnosis other than epilepsy 43 (12) Psychogen
Psychogen
Syncope 
Sleep diso
Panic atta
Tourette s
Hypocalce
Table 2
Pattern of AED usage among patients with uncontrolled seizures.
Diagnosis One AED 
SGE 5 (19%) 
Focal other than TLE 39 (39%) 
IGE 39 (44%) 
TLE 21 (28%) 
UE 9 (60%) 
Diagnosis other than epilepsya 22 (51%) 
AED: antiepileptic drug; SGE: symptomatic generalized epilepsy; TLE: temporal lobe e
a Four patients had both epilepsy and psychogenic non-epileptic seizures.monotherapies or in combination) to achieve sustained seizure
freedom.5 The ﬁrst four categories were considered to be various
forms of pseudointractability.
The data from the patients were kept conﬁdential through
codes. Statistical analyses were performed using Chi-square and
Fisher’s Exact tests to determine potentially signiﬁcant differences,
and a P value less than 0.05 was considered signiﬁcant. This study
was conducted with the approval by Shiraz University of Medical
Sciences Review Board.
3. Results
During the study period, 350 patients were referred to us due to
uncontrolled seizures. One hundred ninety-one (55%) were male
and 159 (45%) were female. The mean age (standard deviation) at
the time of referral was 29 years (10). The minimum age was 18
years and the maximum age was 77 years. Seizure frequency at
referral time was daily in 71 patients (20%), weekly in 58 (17%), and
monthly or occasional in 221 patients (63%). Final diagnoses of these
patients are summarized in Table 1. One hundred thirty seven
patients (39%) were taking one AED, 127 (36%) were taking two AEDs
and 88 (25%) patients were taking more than two AEDs at the time of
referral. The patterns of taking AED(s) among different diagnoses are
summarized in Table 2. EEG ﬁndings in patients with uncontrolled
seizures are summarized in Table 3. Brain MRI ﬁndings in patients
with uncontrolled seizures are summarized in Table 4. Blood works
were not performed in most patients [204 patients (58%)]; and they
were not conclusive in others who had them done (irrespective of the
ﬁnal diagnosis). Just in one patient hypocalcemia was detected.
Presumed reasons for uncontrolled seizures among all patients are
summarized in Table 5. Presumed reasons for uncontrolled seizures
among patients with conﬁrmed epilepsy syndrome are summarized
in Table 6. The most common reason for uncontrolled seizures in
patients with IGE was considered to be taking the wrong AED
(misclassiﬁed epilepsy). However, in patients with focal epilepsy, truec classiﬁcation Number (% from total)
yoclonic epilepsy 55 (16)
ed tonic-clonic seizures only 15 (4)
bsence epilepsy 13 (3)
6 (2)
astaut syndrome 19 (6)
8 (2)
ic non-epileptic seizures 32 (9)
ic non-epileptic seizures accompanied by epilepsy 4 (1)
3 (1)
rder 1 (0.2)
cks 1 (0.2)
yndrome 1 (0.2)
mia 1 (0.2)
Two AEDs Three or more AEDs
7 (26%) 15 (55%)
33 (32%) 29 (29%)
37 (42%) 13 (14%)
29 (39%) 25 (33%)
6 (40%) 0
15 (35%) 6 (14%)
pilepsy; IGE: idiopathic generalized epilepsy; UE: unclassiﬁed epilepsy.
Table 3
Results of EEG studies in patients referred with uncontrolled seizures.
Diagnosis Routine EEG Video-EEG monitoring
Normal Abnormal Not donea Normal Abnormal Not done
SGE 1 (4%) 25 (96%) 1 0 9 (100%) 18
Focal other than TLE 29 (32%) 62 (68%) 10 8 (28%) 21 (72%) 72
IGE 28 (33%) 58 (67%) 3 4 (20%) 16 (80%) 69
TLE 22 (31%) 48 (69%) 5 5 (15%) 29 (85%) 41
UE 11 (85%) 2 (15%) 2 5 (83%) 1 (17%) 9
Diagnosis other than epilepsyb 32 (89%) 4 (11%) 7 25 (86%) 4 (14%) 14
SGE: symptomatic generalized epilepsy; TLE: temporal lobe epilepsy; IGE: idiopathic generalized epilepsy; UE: unclassiﬁed epilepsy.
a In some patients routine EEG was not done due to ﬁnancial reasons.
b Four patients had both epilepsy and psychogenic non-epileptic seizures.
Table 4
Results of brain MRI study in patients referred with uncontrolled seizuresa.
Diagnosis Normal Abnormal Not done
SGE 9 (64%) 5 (36%) 13
Focal other than TLE 24 (25%) 71 (75%) 6
IGE 34 (83%) 7 (17%) 48
TLE 20 (30%) 46 (70%) 8
UE 10 (83%) 2 (17%) 3
Diagnosis other than epilepsyb 13 (72%) 5 (28%) 25
SGE: symptomatic generalized epilepsy; TLE: temporal lobe epilepsy; IGE:
idiopathic generalized epilepsy; UE: unclassiﬁed epilepsy.
a In most patients (other than patients with idiopathic epilepsy syndromes) MRI
was not done due to ﬁnancial reasons.
b Four patients had both epilepsy and psychogenic non-epileptic seizures.
Table 5
Presumed reasons for having uncontrolled seizures among patients.
Reason Number Percent
Medically-refractory epilepsy 139 40
Wrong medication 100 29
Suboptimal dosage of an appropriate AED 63 18
Diagnosis other than epilepsy 43 12
Poor drug compliance 5 1
AED: antiepileptic drug.
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reason; the differences were statistically signiﬁcant (P = 0.0001). It
should be mentioned again that, 61% of the patients were receiving
two or more AEDs at referral and 15% had received two or more AEDs
before, in their drug history (totally, 76% of the patients had two or
more AEDs in their dug history). Those patients [83 patients (24%)],
who were treated with only one AED in their drug history, were most
often those with non-epileptic disorders or those with poor drug
adherence or were categorized as receiving wrong medication or
suboptimal dose of an AED. In other words, in order to comply with
the new deﬁnition of medically-refractory seizures,5 we mentioned
uncontrolled seizures for the reason for referral of the patients to our
clinic and then categorized the patients into ﬁve classes including
those with medically-refractory seizures, if we observed failure ofTable 6
Presumed reasons for having uncontrolled seizures among patients with conﬁrmed ep
Diagnosis Presumed reasons for having uncontrolled seizures
Medically-refractory epilepsy Wrong medicatio
Focal other than TLE 56 (55%) 15 (15%) 
IGE 11 (12%) 62 (69%) 
TLE 54 (72%) 6 (8%) 
SGE 9 (33%) 17 (63%) 
UE 9 (60%) 0 
AED: antiepileptic drug; SGE: symptomatic generalized epilepsy; TLE: temporal lobe eadequate trials of at least two tolerated, appropriately chosen and
used AED schedules in the patient’s drug history.
4. Discussion
Uncontrolled seizures are a commonly encountered problem,
particularly at epilepsy clinics. The health care provider should
ﬁrst try to verify the diagnosis of epilepsy and to ensure that the
patient does not have some other disorders. In the current study,
we observed that a signiﬁcant number (12%) of patients who were
treated for uncontrolled seizures (at times, with multiple AEDs)
had indeed other diagnoses. In a previous study, the overall
misdiagnosis rate was 26%, with incomplete history-taking and
misinterpretation of the EEG equally responsible.6 The observed
difference between these two studies could the result of the
differences in the populations studied or alternatively, due to
methodological differences. However, it is imperative to consider
‘‘misdiagnosis’’ when evaluating a patient with presumably
uncontrolled seizures. The differential diagnosis in adults includes
psychogenic non-epileptic seizures (pseudoseizures), syncope,
sleep disorders, and panic attack, among other possibilities
(migraine, transient ischemic attacks, movement disorders, etc.).
The key step in making a correct diagnosis of epilepsy is having a
standardized approach, particularly with regard to taking a
detailed clinical history.7 If the diagnosis of epilepsy cannot be
established by taking history alone, one should obtain further
testing and diagnostic information. EEG is a valuable ancillary test,
particularly for classiﬁcation of epilepsies. One valuable option is
to obtain long-term video-EEG monitoring. Once epilepsy has been
diagnosed, an AED appropriate for that syndrome may be
prescribed.2,8,9 Despite all the efforts, many individuals with
epilepsy have persistent seizures. Medically-refractory epilepsy is
the most common cause of uncontrolled seizures in adults. In our
study, 40% of adults with uncontrolled seizures had indeed
medically-refractory epilepsy. Medically-refractory epilepsy was
particularly common among patients with focal epilepsy (speciﬁ-
cally, temporal lobe epilepsy) (Table 6). However, if an appropriate
approach has not been practiced in treating the patients with
epilepsy or the patient has not had good drug compliance, he/sheilepsy syndrome.
n Suboptimal dosage of appropriate AED Poor drug compliance
27 (27%) 3 (3%)
15 (17%) 1 (2%)
15 (20%) 0
1 (4%) 0
5 (33%) 1 (7%)
pilepsy; IGE: idiopathic generalized epilepsy; UE: unclassiﬁed epilepsy.
A.A. Asadi-Pooya et al. / Seizure 22 (2013) 271–274274might experience uncontrolled seizures (pseudointractability). In
the current study, pseudointractability was observed in 60% of
adults referred with uncontrolled seizures to our clinic. About, one-
third of patients were experiencing uncontrolled seizures while
taking inappropriate AED(s) for their condition due to misclassiﬁ-
cation of their syndrome (e.g., carbamazepine for absences,
ethosuximide for complex partial seizures, phenytoin for epileptic
spasms, or vigabatrin for myoclonic seizures2). This was particu-
larly common among patients with IGE (Table 6). In a previous
study, only 32% of patients with juvenile myoclonic epilepsy (JME)
were correctly diagnosed at referral. The main factors responsible
for misdiagnosis were failure to elicit a history of myoclonic jerks
and misinterpretation of myoclonic jerks.10 In another study, a
considerable delay of approximately ﬁve years has been observed
in the diagnosis of JME when and where private physicians were
possibly not familiar with this syndrome.11
Consumption of a suboptimal dose of an appropriate antiepi-
leptic drug or poor drug adherence is another possible cause for
pseudointractability in patients with uncontrolled seizures.
Suboptimal adherence to AED treatment is relatively common
among patients with epilepsy.12 This increases the risk of
uncontrolled seizures (pseudointractability), status epilepticus
and even sudden unexplained death in epilepsy. The implementa-
tion of strategies to promote AED adherence could be helpful.12,13
5. Limitation of the study
This was a cross-sectional study. A prospective study with at
least one year follow-up is necessary to ascertain the exact number
of patients with true medically-refractory epilepsy and those with
pseudointractability (to show that in follow-up the revised treat-
ment schedules did in fact lead to remission in the latter group).
6. Conclusion
Uncontrolled seizures are a commonly encountered problem,
particularly at epilepsy clinics.14 One should consider all possible
reasons for these uncontrolled seizures, including non-epileptic
seizures, pseudointractability (misclassiﬁcation and taking the
wrong medication for the speciﬁc epilepsy syndrome; taking
suboptimal doses of an appropriate AED; or poor drug compliance),
and medically-refractory epilepsy. The mainstay for making a
correct diagnosis is having a standardized approach, particularly
with regard to taking a detailed clinical history.Conﬂict of interest
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